• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[TNM 分类法]

[TNM classification].

作者信息

Akaza H

机构信息

Department of Urology, Institute of Clinical Medicine, University of Tsukuba.

出版信息

Nihon Hinyokika Gakkai Zasshi. 1994 Feb;85(2):229-41. doi: 10.5980/jpnjurol1989.85.229.

DOI:10.5980/jpnjurol1989.85.229
PMID:8121105
Abstract

Stage classification of cancer is a method for objectively describing the status of a tumor. For more than 30 years, the TNM classification system was applied on various kind of malignant neoplasms, whose basic principles were: 1) applicability to all anatomic sites; 2) independence from treatment, and 3) susceptibility to further modification on the basis of information supplied by surgery and histopathological description. Thus far, TNM classification system has made a great contribution to 1) aid the clinician in the planning of treatment; 2) give some indication of prognosis; 3) assist in evaluation of the results of treatment; 4) facilitate the exchange of information between treatment centers; 5) contribute to the continuing investigation of human cancer. However, the publication of the fourth edition of the TNM classification has caused great consternation to urologists because of lack of logic for its complete revision. In this review analyses were done on the changes in the TNM classification of the genitourinary tumors described in the 3rd, 4th and 4th revision. Discussion was also made in relation to the TNM systems and classification systems in the general rules for clinical and pathological studies on urological malignancy of Japanese Urological Association.

摘要

癌症分期是一种客观描述肿瘤状态的方法。三十多年来,TNM分期系统应用于各种恶性肿瘤,其基本原则为:1)适用于所有解剖部位;2)与治疗无关;3)可根据手术和组织病理学描述提供的信息进行进一步修订。迄今为止,TNM分期系统在以下方面做出了巨大贡献:1)帮助临床医生制定治疗方案;2)提供一些预后指标;3)协助评估治疗结果;4)促进各治疗中心之间的信息交流;5)推动对人类癌症的持续研究。然而,TNM分期第四版的发布让泌尿外科医生大为惊愕,因为其全面修订缺乏逻辑性。本综述分析了第三版、第四版及第四版修订版中描述的泌尿生殖系统肿瘤TNM分期的变化。还结合日本泌尿外科学会关于泌尿外科恶性肿瘤临床和病理研究的一般规则中的TNM系统及分期系统进行了讨论。

相似文献

1
[TNM classification].[TNM 分类法]
Nihon Hinyokika Gakkai Zasshi. 1994 Feb;85(2):229-41. doi: 10.5980/jpnjurol1989.85.229.
2
TNM: evolution and relation to other prognostic factors.TNM分期:演变及其与其他预后因素的关系。
Semin Surg Oncol. 2003;21(1):3-7. doi: 10.1002/ssu.10014.
3
TNM: principles, history, and relation to other prognostic factors.TNM:原则、历史及与其他预后因素的关系
Cancer. 2001 Apr 15;91(8 Suppl):1589-92. doi: 10.1002/1097-0142(20010415)91:8+<1589::aid-cncr1170>3.0.co;2-k.
4
Cancer staging: future directions for the TNM classification.癌症分期:TNM分类的未来发展方向
Semin Surg Oncol. 1992 Mar-Apr;8(2):107-10. doi: 10.1002/ssu.2980080212.
5
TNM, sixth edition: new developments in general concepts and rules.《肿瘤学分期手册》第六版:一般概念与规则的新进展
Semin Surg Oncol. 2003;21(1):19-22. doi: 10.1002/ssu.10017.
6
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.第八版泌尿生殖系统癌症肿瘤-淋巴结-转移分期分类更新。
Eur Urol. 2018 Apr;73(4):560-569. doi: 10.1016/j.eururo.2017.12.018. Epub 2018 Jan 9.
7
[Principles of the TNM system].[TNM系统的原则]
SSO Schweiz Monatsschr Zahnheilkd. 1978 Mar;88(3):217-32.
8
[The TNM classification adapted to palliative care].[适用于姑息治疗的TNM分期系统]
Bull Cancer. 1991;78(9):769-73.
9
TNM classification of genitourinary tumours 1987--position of the EORTC Genitourinary Group.
Br J Urol. 1988 Dec;62(6):502-10. doi: 10.1111/j.1464-410x.1988.tb04415.x.
10
[Tumor classification--present status and further developments].[肿瘤分类——现状与进一步发展]
Fortschr Med. 1989 Dec 10;107(35):757-9.

引用本文的文献

1
Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer.血清中未检测到的α-klotho与乳腺癌最具侵袭性的表型相关。
Mol Clin Oncol. 2022 Apr;16(4):93. doi: 10.3892/mco.2022.2526. Epub 2022 Feb 25.